Skip to main content
Top
Published in: The Journal of Headache and Pain 1/2022

Open Access 01-12-2022 | Care | Commentary

TIME, to move forward? comment on “a universal outcome measure for headache treatments, care-delivery systems and economic analysis”

Author: Raquel Gil-Gouveia

Published in: The Journal of Headache and Pain | Issue 1/2022

Login to get access

Abstract

The paper from Steiner et al. suggests that an outcome measure expressed in time units may be an adequate method to assess the impact of headache disorders, regardless of diagnosis or health care setting, proving useful for cost-benefit analysis and health policy definition. Using time lost to each attack – weighted by disability – may prove to be a reliable measure to establish the effectiveness of acute treatment, but if considering also the attack frequency it could evaluate the effects of preventive strategies. A measure such as the Headache Gauge, which translates the proportion of time lost to headache -related disability, has proven to be applicable also in routine clinical practice as well, and can be tested in clinical trials and populational analysis. There are practical limitations, such as disability assessment and the need for prospective data collection to avoid recall bias but it seems consensual that impairment related to primary headache disorders is primarily driven by the TIME stolen from the perfect health status.
Literature
1.
go back to reference Gil-Gouveia R, Oliveira AG, Martins IP (2015) The impact of cognitive symptoms on migraine attack-related disability. Cephalalgia 36(5):422–30CrossRef Gil-Gouveia R, Oliveira AG, Martins IP (2015) The impact of cognitive symptoms on migraine attack-related disability. Cephalalgia 36(5):422–30CrossRef
2.
go back to reference Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML (2016) A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability. Headache 56(8):1280–9CrossRef Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML (2016) A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability. Headache 56(8):1280–9CrossRef
4.
go back to reference Steiner TJ, Linde M, Schnell-Inderst P (2021) A universal outcome measure for headache treatments, care-delivery systems and economic analysis. J Headache Pain 22(1):1–10CrossRef Steiner TJ, Linde M, Schnell-Inderst P (2021) A universal outcome measure for headache treatments, care-delivery systems and economic analysis. J Headache Pain 22(1):1–10CrossRef
5.
go back to reference Gil-Gouveia R, Marques IB, Parreira EP, Martins IP, Oliveira AG (2021) Headache Gauge: a real-life calendar-based tool for headache monitoring. Neurol Sci 10:4163–4174CrossRef Gil-Gouveia R, Marques IB, Parreira EP, Martins IP, Oliveira AG (2021) Headache Gauge: a real-life calendar-based tool for headache monitoring. Neurol Sci 10:4163–4174CrossRef
7.
go back to reference McKenzie JA, Cutrer FM (2009) How well do headache patients remember? A comparison of self-report measures of headache frequency and severity in patients with migraine. Headache 49(5):669–72CrossRef McKenzie JA, Cutrer FM (2009) How well do headache patients remember? A comparison of self-report measures of headache frequency and severity in patients with migraine. Headache 49(5):669–72CrossRef
Metadata
Title
TIME, to move forward? comment on “a universal outcome measure for headache treatments, care-delivery systems and economic analysis”
Author
Raquel Gil-Gouveia
Publication date
01-12-2022
Publisher
Springer Milan
Keywords
Care
Headache
Published in
The Journal of Headache and Pain / Issue 1/2022
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-022-01395-y

Other articles of this Issue 1/2022

The Journal of Headache and Pain 1/2022 Go to the issue